Published in Clin Cases Miner Bone Metab on May 01, 2010
Reference values of bone stiffness index and C-terminal telopeptide in healthy European children. Int J Obes (Lond) (2014) 0.85
Bone disorders in children and adolescents with chronic HCV infection. Clin Cases Miner Bone Metab (2014) 0.75
Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Report of a WHO Study Group. World Health Organ Tech Rep Ser (1994) 17.37
The bone mineral density in childhood study: bone mineral content and density according to age, sex, and race. J Clin Endocrinol Metab (2007) 4.00
Quantitative bone analysis in children: current methods and recommendations. J Pediatr (2005) 3.11
Adolescents' self-assessment of sexual maturation. Pediatrics (1980) 3.06
Bone mineral acquisition in healthy Asian, Hispanic, black, and Caucasian youth: a longitudinal study. J Clin Endocrinol Metab (1999) 3.03
Noninvasive assessment of bone mineral and structure: state of the art. J Bone Miner Res (1996) 2.47
Quantitative heel ultrasound as a predictor for osteoporosis. Med J Aust (1999) 2.37
Role of peak bone mass and bone loss in postmenopausal osteoporosis: 12 year study. BMJ (1991) 2.12
Measurement of bone mineral content of the lumbar spine by dual energy x-ray absorptiometry in normal children: correlations with growth parameters. J Clin Endocrinol Metab (1990) 1.83
Pediatric reference curves for multi-site quantitative ultrasound and its modulators. Osteoporos Int (2003) 1.56
Evaluation of cortical bone by computed tomography. J Bone Miner Res (1996) 1.55
Bone mineral content per muscle cross-sectional area as an index of the functional muscle-bone unit. J Bone Miner Res (2002) 1.43
A prospective study of quantitative ultrasound in children and adolescents. J Clin Densitom (2000) 1.41
The "muscle-bone unit" in children and adolescents. Calcif Tissue Int (2002) 1.35
Can the WHO criteria for diagnosing osteoporosis be applied to calcaneal quantitative ultrasound? Osteoporos Int (2000) 1.25
The development of metaphyseal cortex--implications for distal radius fractures during growth. J Bone Miner Res (2001) 1.18
Standards and guidelines for performing central dual-energy x-ray absorptiometry in premenopausal women, men, and children. J Clin Densitom (2004) 1.18
Bone density in children: a review of the available techniques and indications. Eur J Radiol (1998) 1.17
Comparison of bone mineral density and quantitative ultrasound of the calcaneus: site-matched correlation and discrimination of axial BMD status. Br J Radiol (2000) 1.14
Bone mineral density of total body, spine, and femoral neck in children and young adults: a cross-sectional and longitudinal study. J Bone Miner Res (1994) 1.14
Phalangeal osteosonogrammetry study: age-related changes, diagnostic sensitivity, and discrimination power. The Phalangeal Osteosonogrammetry Study Group. J Bone Miner Res (2000) 1.13
Variations in hip fracture hospitalization rates among different race/ethnicity groups in New York City. Ethn Dis (2004) 1.08
Accounting for body size deviations when reporting bone mineral density variables in children. Osteoporos Int (2008) 1.08
Ultrasound bone measurement in pediatric subjects. Calcif Tissue Int (1995) 1.08
Bone mass and hip axis length in healthy Asian, black, Hispanic, and white American youths. J Bone Miner Res (1997) 1.07
Overdiagnosis of osteoporosis in children due to misinterpretation of dual-energy x-ray absorptiometry (DEXA). J Pediatr (2004) 1.06
Prediction models for evaluation of total-body bone mass with dual-energy X-ray absorptiometry among children and adolescents. Pediatrics (2004) 1.04
Ethnic and gender differences in bone mineral density and bone turnover in young adults: effect of bone size. Osteoporos Int (2000) 0.97
Osteoporosis as a pediatric problem. Pediatr Clin North Am (1995) 0.97
Adapting pediatric DXA scanning to clinical orthopaedics. J Pediatr Orthop (2006) 0.96
Bone density interpretation and relevance in Caucasian children aged 9-17 years of age: insights from a population-based fracture study. J Clin Densitom (2006) 0.96
Bone mineral density, ultrasound velocity, and broadband attenuation predict mechanical properties of trabecular bone differently. Bone (2002) 0.95
Bone mineral density in postmenarchal adolescent girls in the United States: associated biopsychosocial variables and bone turnover markers. J Adolesc Health (2006) 0.94
An in vitro investigation of the dependence on sample thickness of the speed of sound along the specimen. Med Eng Phys (1999) 0.94
Multisite quantitative ultrasound: precision, age- and menopause-related changes, fracture discrimination, and T-score equivalence with dual-energy X-ray absorptiometry. Osteoporos Int (2001) 0.92
Calcaneus ultrasound measurements in a convenience sample of healthy youth. J Clin Densitom (2001) 0.91
Bone quality assessment by quantitative ultrasound of proximal phalanxes of the hand in healthy subjects aged 3--21 years. Pediatr Res (2001) 0.90
Assessment of bone status using speed of sound at multiple anatomical sites. Ultrasound Med Biol (2001) 0.89
Reference values for quantitative ultrasonography (QUS) of radius and tibia in healthy greek pediatric population: clinical correlations. J Clin Densitom (2009) 0.86
The role of quantitative ultrasound in predicting osteoporosis defined by dual X-ray absorptiometry. Rheumatol Int (2001) 0.85
Reference values for bone mineral density in 12- to 18-year-old girls categorized by weight, race, and age. Pediatr Radiol (2004) 0.85
Bone status evaluation with calcaneal ultrasound in children with chronic rheumatic diseases. A one year followup study. J Rheumatol (2003) 0.84
Diagnostic value of ultrasound analysis and bone densitometry as predictors of vertebral deformity in postmenopausal women. Osteoporos Int (1995) 0.84
How does quantitative ultrasound compare to dual X-ray absorptiometry at various skeletal sites in relation to the WHO diagnosis categories? Clin Physiol (2001) 0.83
German pediatric reference data for quantitative transverse transmission ultrasound of finger phalanges. Osteoporos Int (2002) 0.83
Comparison of quantitative calcaneal ultrasound and dual energy X-ray absorptiometry in the evaluation of osteoporotic risk in children with chronic rheumatic diseases. Calcif Tissue Int (2000) 0.83
Influence of age, sex, and growth variables on phalangeal quantitative ultrasound measures: a study in healthy children and adolescents. Calcif Tissue Int (2003) 0.83
Ultrasound bone densitometry of the os calcis in children and adolescents. Calcif Tissue Int (2000) 0.83
Ultrasound velocity through the cortex of phalanges, radius, and tibia in normal and osteoporotic postmenopausal women using a new multisite quantitative ultrasound device. Invest Radiol (2003) 0.82
A reference database for the Stratec XCT-2000 peripheral quantitative computed tomography (pQCT) scanner in healthy children and young adults aged 6-19 years. Osteoporos Int (2008) 0.82
Tibial quantitative ultrasound versus whole-body and lumbar spine DXA in a Dutch pediatric and adolescent population. Invest Radiol (2000) 0.80
Quantitative tibial ultrasonometry versus radiographic phalangeal absorptiometry in a Caucasian pediatric population. Calcif Tissue Int (2001) 0.80
Comparison between quantitative calcaneal and tibial ultrasound in a Dutch Caucasian pediatric and adolescent population. J Clin Densitom (2001) 0.79
Comparison of quantitative ultrasound parameters with dual energy X-ray absorptiometry in pre- and postmenopausal women. Neth J Med (2001) 0.79
Potential roles for quantitative ultrasound in the management of osteoporosis. Med J Aust (2000) 0.79
Racial difference in the correlates of bone mineral content/density and age at peak among reproductive-aged women. Osteoporos Int (2009) 0.78
Ultrasound velocity and attenuation at different skeletal sites compared with bone mineral density measured using dual energy X-ray absorptiometry. Br J Radiol (1996) 0.77
[Ultrasound bone densitometry in children and adolescents; Italian refence curves with multi-site device (Omnisense)]. Pediatr Med Chir (2007) 0.77
[Progress in measurement of the calcaneus using ultrasonic methods in children and adolescents]. Przegl Lek (2000) 0.76
Prevention in pediatric orthopaedics. J Pediatr Orthop B (2002) 0.76
DXA of the hip and heel ultrasound but not densitometry of the fingers can discriminate female hip fracture patients from controls: a comparison between four different methods. Osteoporos Int (2001) 0.75
Systematic microanatomical analysis of CXCL13 and CCL21 in situ production and progressive lymphoid organization in rheumatoid synovitis. Eur J Immunol (2005) 1.96
Phenylethynyl-pyrrolo[1,2-a]pyrazine: a new potent and selective tool in the mGluR5 antagonists arena. Bioorg Med Chem Lett (2008) 1.40
Activation of WNT and BMP signaling in adult human articular cartilage following mechanical injury. Arthritis Res Ther (2006) 1.31
CLEC-2 and Syk in the megakaryocytic/platelet lineage are essential for development. Blood (2011) 1.30
Increased circulating levels and salivary gland expression of interleukin-18 in patients with Sjögren's syndrome: relationship with autoantibody production and lymphoid organization of the periductal inflammatory infiltrate. Arthritis Res Ther (2004) 1.10
Inducible tertiary lymphoid structures, autoimmunity, and exocrine dysfunction in a novel model of salivary gland inflammation in C57BL/6 mice. J Immunol (2012) 0.99
Lymphoid aggregates that resemble tertiary lymphoid organs define a specific pathological subset in metal-on-metal hip replacements. PLoS One (2013) 0.97
Stable expression and functional characterization of a human nicotinic acetylcholine receptor with α6β2 properties: discovery of selective antagonists. Br J Pharmacol (2011) 0.92
Reduced circulating natural killer T cells and gamma/delta T cells in patients with systemic sclerosis. J Rheumatol (2005) 0.92
Stromal cells in chronic inflammation and tertiary lymphoid organ formation. Annu Rev Immunol (2015) 0.90
Markedly increased IL-18 liver expression in adult-onset Still's disease-related hepatitis. Rheumatology (Oxford) (2010) 0.90
Lambda light chain revision in the human intestinal IgA response. J Immunol (2008) 0.87
Atorvastatin fails to prevent the development of autoimmune diabetes despite inhibition of pathogenic beta-cell-specific CD8 T-cells. Diabetes (2006) 0.85
Synthesis and SAR of substituted tetrahydrocarbazole derivatives as new NPY-1 antagonists. Bioorg Med Chem Lett (2005) 0.85
Exploration of the amine terminus in a novel series of 1,2,4-triazolo-3-yl-azabicyclo[3.1.0]hexanes as selective dopamine D3 receptor antagonists. J Med Chem (2010) 0.83
Generation of Immunoglobulin diversity in human gut-associated lymphoid tissue. Semin Immunol (2009) 0.83
Biologic treatments in Sjögren's syndrome. Presse Med (2012) 0.81
Antisense transcripts of V(D)J rearrangements; artifacts caused by false priming? Mol Immunol (2009) 0.81
Peroxisome proliferator-activated receptor-γ agonist rosiglitazone prevents albuminuria but not glomerulosclerosis in experimental diabetes. Am J Nephrol (2010) 0.81
6-(3,4-dichlorophenyl)-1-[(methyloxy)methyl]-3-azabicyclo[4.1.0]heptane: a new potent and selective triple reuptake inhibitor. J Med Chem (2010) 0.80
Occurrence and Duration of Interruptions During Nurses' Work in Surgical Wards: Findings From a Multicenter Observational Study. J Nurs Care Qual (2016) 0.80
Granulomatosis with polyangiitis involves sustained mucosal inflammation that is rich in B-cell survival factors and autoantigen. Rheumatology (Oxford) (2012) 0.80
Resistance to rituximab therapy and local BAFF overexpression in Sjögren's syndrome-related myoepithelial sialadenitis and low-grade parotid B-cell lymphoma. Open Rheumatol J (2008) 0.79
6-[2-(4-Aryl-1-piperazinyl)ethyl]-2H-1,4-benzoxazin-3(4H)-ones: dual-acting 5-HT1 receptor antagonists and serotonin reuptake inhibitors. Bioorg Med Chem Lett (2008) 0.79
Chiral tetrahydroquinoline derivatives as potent anti-hyperalgesic agents in animal models of sustained inflammation and chronic neuropathic pain. Bioorg Med Chem Lett (2006) 0.79
Subepithelial dendritic B cells in orofacial granulomatosis. Inflamm Bowel Dis (2010) 0.79
1-(Aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes and 6-(aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes: a new series of potent and selective triple reuptake inhibitors. J Med Chem (2010) 0.78
Synthetic peptides as substrate for assaying the proteolytic activity of Lactobacillus helveticus. J Dairy Res (2003) 0.76
Novel stereocontrolled addition of allylmetal reagents to alpha-imino esters: efficient synthesis of chiral tetrahydroquinoline derivatives. J Org Chem (2002) 0.75
Enantiomerically pure tetrahydroquinoline derivatives as in vivo potent antagonists of the glycine binding site associated to the NMDA receptor. Bioorg Med Chem Lett (2003) 0.75
5-{2-[4-(2-methyl-5-quinolinyl)-1-piperazinyl]ethyl}-2(1H)-quinolinones and 3,4-dihydro-2(1H)-quinolinones: dual-acting 5-HT1 receptor antagonists and serotonin reuptake inhibitors. Part 3. Bioorg Med Chem Lett (2010) 0.75
Benzoazepine derivative as potent antagonists of the glycine binding site associated to the NMDA receptor. Farmaco (2003) 0.75
8-[2-(4-Aryl-1-piperazinyl)ethyl]-2H-1,4-benzoxazin-3(4H)-ones: dual-acting 5-HT1 receptor antagonists and serotonin reuptake inhibitors--part II. Bioorg Med Chem Lett (2009) 0.75